Pyrimidine derivatives as orexin receptor antagonists

Details Pyrimidine derivatives as orexin receptor antagonists Pyrimidine derivatives as orexin receptor antagonists

2006-08-10

2010-10-12

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S332000, C544S330000, C544S331000, C544S333000, C544S335000

Reexamination Certificate

active

07812031

ABSTRACT:
The present invention relates to substituted pyrimidine compounds of formula I useful as orexin receptor antagonists. The invention also relates to pharmaceutical compositions containing said compounds.

REFERENCES:
patent: 2514380 (1950-07-01), Duschinsky et al.
patent: 2835669 (1958-05-01), Otto
patent: 3467662 (1969-09-01), Frey
patent: 3821244 (1974-06-01), Matier
patent: 4698340 (1987-10-01), Takaya et al.
patent: 6274588 (2001-08-01), Boes
patent: 7288544 (2007-10-01), Ohno et al.
patent: 244321 (1912-03-01), None
patent: 1955318 (1970-06-01), None
patent: 2241305 (1975-03-01), None
patent: 1 159 263 (1969-07-01), None
patent: WO 01 96302 (2001-12-01), None
patent: WO/03/051872 (2002-12-01), None
patent: WO 03 051872 (2003-06-01), None
patent: WO 2004 041791 (2004-05-01), None
patent: WO 2004 041816 (2004-05-01), None
patent: WO 2006050476 (2004-11-01), None
Winrow, et al., Neuropharmacol., vol. 58, #1, Jan. 2010, 185-194.
Vianna, Autonomic Neuroscience: Basic & Clinical (Abstracts) 149 (2009) 1-126.
Baker B. R. Shapiro H. S, Analogs ofTetrahydrofolic Acid. IX. Synthesis of N-′1-(2-Amino-4-hydroxy-6-phenyl-5-pyrimid yi)-3-propyl ?p-aminobenzoyl-L-glumtamic Acid, a “Nonclassical” Inhibitor of Some Folic CoFactor Area Enzymes—Journal of Medicinal Chemistry, vol. 6, 1963, pp. 664-669.
Breaux E. J. et al , An improved general synthesis of 4-aryl-5-pyrimidinecarboxylates , Journal of Heterocyclic Chemistry, Heterocorporation, Provo, US, vol. 18, Jan. 1981 pp. 183-184.
Deshmukh M.D et al., Efficient Method for Deamination of Amino pyridines National Academy Science Letters, vol. 21, No. 7, 1998, pp. 247-249.
Dorigo P, Benetollo F. et al , Synthesis and Cardiotonic Activity of Novel Pyrimidine Derivatives: Crystallographic and Quantum Chemical Studies, Journal of Medicinal Chemistry, vol. 39, 1966, pp. 3671-3683.
Matosiuk D et al , Synthesis and CNS Activity of 1-alky-5-arylimidazolidine-2-thiones , Pharmazie, vol. 52, No. 11, 1997, pp. 71-72.
Palankl M. S.S . et al , Structure-Activity Relationship Studies ofEthyl 2-′(3-Methyl-2,5-dioxo(3-pyrrolinyl)) amino?-4-(trifluoromethyl)pyrimidine-4-carboxyl ate: An Inhibitor of AP-1 and nF-kb Medicated Gene Expression Bioorganic & Medicinal Chemistry Letters, vol. 12, 2002, pp. 2573-2577.
Rezende M.C. et al , The Preparation of Potentially Psychoactive beta-alkoxyphenethylamines, Synthetic Communications, vol. 25, No. 8, 1995, pp. 1239-1247.
Shih N-Y et al , Trans-4-Methyl-3-Imidazoyl Pyrrolidine as a potent, highly selective Histamine H3 Receptor Agonist in Vivo, Bioorganic & Medicinal Chemistry Letters, vol. 8, 1988, pp. 243-248.
WeInhardt K et al , Synthesis and Central Nervous System Properties of 2-′(Alkoxycarbonyl)amino?-4(5)-phenyl-2-im idazolines, Journal of Medicinal Chemistry, vol. 27, 1984, pp. 616-627.

Affiliated with

Also associated with

Rating

Pyrimidine derivatives as orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine derivatives as orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as orexin receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4167761